Position in ZTS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$94,207
-$176,965 QoQ
Shares Held
1,311
-42.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,100
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 21%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $344,932 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,311 | $94,207 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,795 | $60,814 | |
| 3 | VTRS |
Viatris Inc
|
3,809 | $60,486 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
295 | $49,719 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,108 | $33,791 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
55 | $29,800 | |
| 7 | HLN |
Haleon plc
|
1,727 | $16,112 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
70 | $3 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,207 | 1,311 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $271,172 | 2,294 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $288,630 | 2,294 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $322,196 | 2,202 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $344,649 | 2,210 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $363,875 | 2,210 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $352,579 | 2,164 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $409,125 | 2,094 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $316,728 | 1,827 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $303,392 | 1,793 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $365,331 | 1,851 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $345,523 | 1,986 | Shares | Defined | 2023-11-06 | |
| 2023-06-30 | $361,812 | 2,101 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $316,235 | 1,900 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $278,444 | 1,900 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $297,617 | 2,007 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $344,982 | 2,007 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $326,637 | 1,732 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $416,070 | 1,705 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $333,726 | 1,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $320,352 | 1,719 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $268,818 | 1,707 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $282,508 | 1,707 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $266,245 | 1,610 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $191,169 | 1,395 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $139,697 | 1,187 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||